Cargando…

Specific treatments in the critically ill COVID-19 patients: benefits and toxicities

Detalles Bibliográficos
Autor principal:	Mégarbane, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461786/ http://dx.doi.org/10.1016/S0378-4274(21)00277-0

Ejemplares similares

The presence of Pneumocystis jirovecii in critically ill patients with COVID-19
por: Alanio, Alexandre, et al.
Publicado: (2021)

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
por: Alanio, Alexandre, et al.
Publicado: (2020)

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
por: Siguret, Virginie, et al.
Publicado: (2020)

Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients
por: Voicu, Sebastian, et al.
Publicado: (2021)

Toxic Bradycardias in the Critically Ill Poisoned Patient
por: Givens, Melissa L.
Publicado: (2012)

Critically ill COVID-19 patient
por: HALAÇLI, Burçin, et al.
Publicado: (2020)

COVID-19 in the Critically Ill Patient
por: Bell, Taison D.
Publicado: (2022)

Specific nutrition and metabolic characteristics of critically ill patients with persistent COVID‐19
por: Viana, Marina V., et al.
Publicado: (2022)

Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021)

Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients
por: M, Montero-Baladía, et al.
Publicado: (2020)

Caring for the Critically Ill Patient with COVID-19
por: Hensley, Matthew K., et al.
Publicado: (2022)

COVID-19 in the Critically Ill Pregnant Patient
por: Levitus, Matthew, et al.
Publicado: (2022)

Survival Benefit of Corticosteroid Replacement in Critically Ill Patients: One Treatment Effect or Two?
por: Laies, Slavita M, et al.
Publicado: (2021)

The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients
por: Boyd, Sean, et al.
Publicado: (2021)

Nutritional therapy in Covid-19 critically ill patients
por: Castro, M., et al.
Publicado: (2020)

Ribavirin Treatment for Critically Ill COVID-19 Patients: An Observational Study
por: Xu, Yonghao, et al.
Publicado: (2021)

Outcome of Critically Ill COVID-19 Patients According to the Setting of Corticosteroid Initiation—A Retrospective Observational Cohort Study
por: Voicu, Sebastian, et al.
Publicado: (2021)

Metoprolol in Critically Ill Patients With COVID-19
por: Clemente-Moragón, Agustín, et al.
Publicado: (2021)

BAROTRAUMA IN CRITICALLY ILL PATIENTS WITH COVID-19
por: MURAG, SOUMYA, et al.
Publicado: (2021)

Transport of critically ill COVID-19 patients
por: Yousuf, Beena, et al.
Publicado: (2020)

Benefit versus toxicity risk of digoxin in patients with COVID-19
por: Kelleci Cakir, Burcu, et al.
Publicado: (2022)

Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients With COVID-19 Infection
por: Schoninger, Scott, et al.
Publicado: (2022)

Tocilizumab in critically ill COVID-19 patients: An observational study
por: Mushtaq, Muhammad Z., et al.
Publicado: (2022)

Pharmacokinetics of enoxaparin in COVID-19 critically ill patients
por: Zufferey, Paul Jacques, et al.
Publicado: (2021)

Neuromuscular involvement in COVID-19 critically ill patients
por: Cabañes-Martínez, Lidia, et al.
Publicado: (2020)

Pulmonary thromboembolism in critical ill COVID-19 patients
por: Scialpi, Michele, et al.
Publicado: (2020)

Pharmacokinetics of baricitinib in critically ill COVID-19 patients
por: Massart, Nicolas, et al.
Publicado: (2023)

COVID-19 critical illness in pregnancy
por: Lapinsky, Stephen E, et al.
Publicado: (2021)

Weighing risks and benefits of stress ulcer prophylaxis in critically ill patients
por: Chanpura, Trupesh, et al.
Publicado: (2012)

Potential benefits of vitamin D for sepsis prophylaxis in critical ill patients
por: Guan, Jianbin, et al.
Publicado: (2023)

Recommendations for treatment of critically ill patients with COVID-19: Version 3 S1 guideline
por: Kluge, S., et al.
Publicado: (2020)

Open Tracheostomy for Critically Ill Patients with COVID-19
por: Hernández-García, Estefanía, et al.
Publicado: (2020)

Correction to: The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients
por: Boyd, Sean, et al.
Publicado: (2022)

Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19
por: Ruiz, S., et al.
Publicado: (2021)

Delirium in Critically Ill Cancer Patients With COVID-19
por: Bjerre Real, Christian, et al.
Publicado: (2022)

Transcriptomic clustering of critically ill COVID-19 patients
por: López-Martínez, Cecilia, et al.
Publicado: (2023)

Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients – A narrative review and hypotheses
por: Gouda, Ahmed S., et al.
Publicado: (2021)

Toxic epidermal necrolysis: a paradigm of critical illness
por: Estrella-Alonso, Alfonso, et al.
Publicado: (2017)

The midline venous catheter in critically ill COVID-19 patients
por: Blanco, P., et al.
Publicado: (2022)

The midline venous catheter in critically ill COVID-19 patients
por: Blanco, P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q5gjgjeg9pt7ibpa3j6s3fvprt